Keywords: Daiichi Sankyo, Denosumab, Osteoporosis, Regulatory filing, Japan, Amgen

Daiichi Sankyo files denosumab in Japan for osteoporosis

Article | 26 March 2012

Print This

Japanese drug major Daiichi Sankyo (TYO: 4568) revealed on Friday that it has filed for approval in Japan to market AMG 162 ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in